Work

Abstract 1652: Preclinical characterization of ICT-011, a first-in-class, highly selective, potent and orally bioavailable MET degrader for the treatment of NSCLC harboring MET amplification

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-1652

Authors: Jong Seok Kang, Yo Han Hong, Yong Hwan Kim, Hyeji Lee, Ji-Seong Yoon, Kyusic Jang, Bo Kyoung Kim, Young-Jun Shin, Moon Hwan Kim, Hye-Dong Yoo

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409689190

Cites:

Cited by:

Related to: 10